This observation implies that in addition to its role as an inhibitor of the SRC-3 oncogene in cancer cells, SI-2-mediated inhibition of SRC-3 in immune cells plays an essential role in tumor growth inhibition. The gene discussed is NCOA3; the disease is cancer.